February 5, 2025: Ozempic Lawsuits Surpass 1400 as More Consumers Speak Out About GLP-1 Complications Novo Nordisk and other GLP-1 drug makers are facing 1,443 lawsuits in the current federal multidistrict litigation against it
A 2025 meta-analysis in PMC (covering 36,754 tirzepatide and 106,057 semaglutide participants across multiple studies) confirmed tirzepatides advantage, finding an average 4.23 percentage points greater weight loss with tirzepatide an effect that was both dose- and duration-dependent
(1 unit corresponds to one division on the dial) and inject into the abdominal area
Recalls & Warnings February 22, 2021 Canadian Creatine Recalled for Dangerous Levels of Vitamin D On February 21, 2021, the Canadian company Genex Nutraceuticals recalled one lot of Perfect Sports Core Series Pure Creatine (also known as Creatine Powder) because it "contains vitamin D that is not listed on the label, at dangerous levels
For Zepbound, Medicare Advantage coverage depends on whether the plan includes an OSA rider
As these recent studies show that higher oral doses of L-carnitine can promote atherogenesis and CVD risk, these findings also support our contention of limiting the oral maintenance dosing of L-carnitine to 3 g per day in the setting of acute MI and call for further investigation on the long-term risks of chronic L-carnitine supplementation in CVD patients